Increased Cardiovascular Mortality in Hemodialysis: The Role of Chronic Inflammation, Complement Activation, and Non-Biocompatibility

Background: Chronic kidney disease (CKD) is an established global health problem, with the increased prevalence of vascular inflammation, accelerated atherogenesis, and thrombotic risk all contributing to overall cardiovascular risk. The major CKD-specific risk factor is presumed to be the accumulat...

Full description

Saved in:
Bibliographic Details
Main Authors: Ákos Géza Pethő, Tibor Fülöp, Petronella Orosz, Gábor Szénási, Mihály Tapolyai, László Dézsi
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Toxins
Subjects:
Online Access:https://www.mdpi.com/2072-6651/17/7/345
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849418254487912448
author Ákos Géza Pethő
Tibor Fülöp
Petronella Orosz
Gábor Szénási
Mihály Tapolyai
László Dézsi
author_facet Ákos Géza Pethő
Tibor Fülöp
Petronella Orosz
Gábor Szénási
Mihály Tapolyai
László Dézsi
author_sort Ákos Géza Pethő
collection DOAJ
description Background: Chronic kidney disease (CKD) is an established global health problem, with the increased prevalence of vascular inflammation, accelerated atherogenesis, and thrombotic risk all contributing to overall cardiovascular risk. The major CKD-specific risk factor is presumed to be the accumulation of uremic toxins in circulation and tissues, further accelerating the progression of CKD and its co-morbidities, including those of bone mineral disorders and cardiovascular diseases. Materials and Methods: In our narrative review, we focused on non-traditional cardiovascular risk factors, as they evolve with declined kidney function and are potentially further modulated by the choice of kidney replacement therapy. Results: Based on the data from the literature to date, the pre-eminent role of non-traditional risk factors emerges to mediate inflammation and increased cardiovascular mortality. In particular, patients receiving hemodialysis (HD) display dramatically increased CVD-mediated mortality. This intensified state of inflammation may be linked to the direct exposure of the bloodstream to a bio-incompatible environment in HD; for both complement-mediated and non-complement-mediated reactions, the possible contribution of neutrophil extracellular traps and complement activation-related pseudoallergy are reviewed in detail. Conclusions: Our narrative review emphasizes key elements of a bio-incompatible HD environment that may contribute to increased cardiovascular mortality in patients receiving HD. Summarizing these results may provide conceptual opportunities to develop new therapeutic targets.
format Article
id doaj-art-338ba2fc91d943e7bbf83ec89f8ec4af
institution Kabale University
issn 2072-6651
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Toxins
spelling doaj-art-338ba2fc91d943e7bbf83ec89f8ec4af2025-08-20T03:32:28ZengMDPI AGToxins2072-66512025-07-0117734510.3390/toxins17070345Increased Cardiovascular Mortality in Hemodialysis: The Role of Chronic Inflammation, Complement Activation, and Non-BiocompatibilityÁkos Géza Pethő0Tibor Fülöp1Petronella Orosz2Gábor Szénási3Mihály Tapolyai4László Dézsi5Department of Internal Medicine and Oncology, Faculty of Medicine, Semmelweis University, 1000 Budapest, HungaryMedicine Service, Ralph H. Johnson VA Medical Center, Charleston, SC 29401, USABethesda Children’s Hospital, 1146 Budapest, HungaryInstitute of Translational Medicine, Semmelweis University, 1085 Budapest, HungaryMedicine Service, Ralph H. Johnson VA Medical Center, Charleston, SC 29401, USAInstitute of Translational Medicine, Semmelweis University, 1085 Budapest, HungaryBackground: Chronic kidney disease (CKD) is an established global health problem, with the increased prevalence of vascular inflammation, accelerated atherogenesis, and thrombotic risk all contributing to overall cardiovascular risk. The major CKD-specific risk factor is presumed to be the accumulation of uremic toxins in circulation and tissues, further accelerating the progression of CKD and its co-morbidities, including those of bone mineral disorders and cardiovascular diseases. Materials and Methods: In our narrative review, we focused on non-traditional cardiovascular risk factors, as they evolve with declined kidney function and are potentially further modulated by the choice of kidney replacement therapy. Results: Based on the data from the literature to date, the pre-eminent role of non-traditional risk factors emerges to mediate inflammation and increased cardiovascular mortality. In particular, patients receiving hemodialysis (HD) display dramatically increased CVD-mediated mortality. This intensified state of inflammation may be linked to the direct exposure of the bloodstream to a bio-incompatible environment in HD; for both complement-mediated and non-complement-mediated reactions, the possible contribution of neutrophil extracellular traps and complement activation-related pseudoallergy are reviewed in detail. Conclusions: Our narrative review emphasizes key elements of a bio-incompatible HD environment that may contribute to increased cardiovascular mortality in patients receiving HD. Summarizing these results may provide conceptual opportunities to develop new therapeutic targets.https://www.mdpi.com/2072-6651/17/7/345hemodialysisperitoneal dialysisimmunologicalbiocompatibilitymortalitychronic inflammation
spellingShingle Ákos Géza Pethő
Tibor Fülöp
Petronella Orosz
Gábor Szénási
Mihály Tapolyai
László Dézsi
Increased Cardiovascular Mortality in Hemodialysis: The Role of Chronic Inflammation, Complement Activation, and Non-Biocompatibility
Toxins
hemodialysis
peritoneal dialysis
immunological
biocompatibility
mortality
chronic inflammation
title Increased Cardiovascular Mortality in Hemodialysis: The Role of Chronic Inflammation, Complement Activation, and Non-Biocompatibility
title_full Increased Cardiovascular Mortality in Hemodialysis: The Role of Chronic Inflammation, Complement Activation, and Non-Biocompatibility
title_fullStr Increased Cardiovascular Mortality in Hemodialysis: The Role of Chronic Inflammation, Complement Activation, and Non-Biocompatibility
title_full_unstemmed Increased Cardiovascular Mortality in Hemodialysis: The Role of Chronic Inflammation, Complement Activation, and Non-Biocompatibility
title_short Increased Cardiovascular Mortality in Hemodialysis: The Role of Chronic Inflammation, Complement Activation, and Non-Biocompatibility
title_sort increased cardiovascular mortality in hemodialysis the role of chronic inflammation complement activation and non biocompatibility
topic hemodialysis
peritoneal dialysis
immunological
biocompatibility
mortality
chronic inflammation
url https://www.mdpi.com/2072-6651/17/7/345
work_keys_str_mv AT akosgezapetho increasedcardiovascularmortalityinhemodialysistheroleofchronicinflammationcomplementactivationandnonbiocompatibility
AT tiborfulop increasedcardiovascularmortalityinhemodialysistheroleofchronicinflammationcomplementactivationandnonbiocompatibility
AT petronellaorosz increasedcardiovascularmortalityinhemodialysistheroleofchronicinflammationcomplementactivationandnonbiocompatibility
AT gaborszenasi increasedcardiovascularmortalityinhemodialysistheroleofchronicinflammationcomplementactivationandnonbiocompatibility
AT mihalytapolyai increasedcardiovascularmortalityinhemodialysistheroleofchronicinflammationcomplementactivationandnonbiocompatibility
AT laszlodezsi increasedcardiovascularmortalityinhemodialysistheroleofchronicinflammationcomplementactivationandnonbiocompatibility